Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Novakand Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Turnover 14 More Arrow 1,035 Less Arrow 753
Financial expenses 0 More Arrow 130 More Arrow 618
Earnings before taxes -44,566 Less Arrow -64,889 More Arrow -52,484
EBITDA -46,161 Less Arrow -65,042 More Arrow -51,574
Total assets 66,911 Less Arrow 65,643 More Arrow 120,738
Current assets 48,910 Less Arrow 47,642 More Arrow 99,490
Current liabilities 4,611 More Arrow 17,978 Less Arrow 13,826
Equity capital 62,300 Less Arrow 47,665 More Arrow 106,912
- share capital 11,778 Less Arrow 7,921 More Arrow 66,273
Employees (average) 5 Less Arrow 4 More Arrow 8

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Solvency 93.1% Less Arrow 72.6% More Arrow 88.5%
Turnover per employee 3 More Arrow 259 Less Arrow 94
Profit as a percentage of turnover -318328.6% More Arrow -6269.5% Less Arrow -6970.0%
Return on assets (ROA) -66.6% Less Arrow -98.7% More Arrow -43.0%
Current ratio 1060.7% Less Arrow 265.0% More Arrow 719.6%
Return on equity (ROE) -71.5% Less Arrow -136.1% More Arrow -49.1%
Change turnover -1,021 More Arrow 282 Less Arrow -951
Change turnover % -99% More Arrow 37% Less Arrow -56%
Chg. No. of employees 1 Less Arrow -4 More Arrow 0
Chg. No. of employees % 25% Less Arrow -50% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 (consolidated) 2022/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.